feed,title,long_url,short_url
Benzinga,"Myasthenia Gravis Treatment Market to Reach $3.1 Billion, Globally, by 2032 at 6.5% CAGR: Allied Market Research",https://benzinga.com/pressreleases/23/05/g32412516/myasthenia-gravis-treatment-market-to-reach-3-1-billion-globally-by-2032-at-6-5-cagr-allied-market,
